Validation of an AI-Assisted Pancreatic EUS System for Training Improvement: a Prospective, Multi-Center, Randomized Trial
Recruiting now · Not applicable
Conditions studied: Pancreatic Diseases
In brief
The goal of this clinical trial is to verify the auxiliary role of the artificial intelligence (AI) system in pancreatic endoscopic ultrasound (EUS) scans. The main questions it aims to answer are as follows: 1. A comparison of the image recognition accuracy between the AI system and EUS endoscopists. 2. Whether the AI system can improve the quality of scans for EUS endoscopists. Participants will conduct EUS scanning with or without the assistance of the AI system.
Key facts
- Study ID
- NCT06790134
- Run by
- The Third Xiangya Hospital of Central South University
- People needed
- 200
- Starts
- 2025-01-15
- Expected to finish
- 2026-03-30
- Last updated by the study team
- 2025-01-23
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age ≥18 years old, <80 years old 2.Patients who need endoscopic ultrasonography of pancreas; 3. Agree to participate in this study and sign the informed consent form.
You may not qualify if…
- Subjects who meet any of the following criteria cannot be selected for this trial:
- First. The patient's physical condition does not meet the requirements of conventional endoscopic ultrasonography:
- Poor physical condition, including hemoglobin ≤8.0g/dl, severe cardiopulmonary insufficiency, etc. Anesthesia assessment failed Pregnancy or breastfeeding In the acute stage of chemical and corrosive injury, it is very easy to cause perforation Recent acute coronary syndrome or clinically unstable ischemic heart attack Heart disease patients with right-to-left shunt, patients with severe pulmonary hypertension (pulmonary artery pressure> 90mmHg), patients with uncontrolled systemic hypertension and patients with adult respiratory distress syndrome.
- Second. Disagree to participate in this study.
- Third. There are other problems that do not meet the requirements of this research or that affect the results of the research:
- Pancreatic disease has undergone surgery or radiotherapy and chemotherapy beforehand; Mental illness, drug addiction, inability to express themselves or other diseases that may affect follow-up.
Where it is running
- The Third Xiangya Hospital of Central South University — Changsha, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.